一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Analytical Chemistry>Standard>Pharmaceutical Impurity Reference Standards>Lapatinib Impurity12
Lapatinib Impurity12
  • Lapatinib Impurity12
  • Lapatinib Impurity12
  • Lapatinib Impurity12
  • Lapatinib Impurity12
  • Lapatinib Impurity12

Lapatinib Impurity12 NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-12-16

Product Details

Product Name: Lapatinib Impurity12 CAS No.: 697299-82-4
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/12/16
Molecular formula: C26H20ClFN4O2

Lapatinib Impurity 12;697299-82-4

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

  • Product Number: L079012
    English Name: Lapatinib Impurity 12
    English Alias: 6-(5-(aminomethyl)furan-2-yl)-N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)quinazolin-4-amine
    CAS Number: 697299-82-4
    Molecular Formula: C26H20ClFN4O2
    Molecular Weight: 474.91

  • Product Advantages: Lapatinib Impurity 12 has extremely high purity, and its structure is accurately confirmed by high-precision spectroscopic analysis (such as nuclear magnetic resonance and mass spectrometry). It has stable chemical properties and maintains good uniformity under different experimental conditions and storage environments. As a professional reference substance, it can ensure the accuracy and repeatability of Lapatinib impurity detection results, providing a reliable basis for pharmaceutical quality research and quality control, and strongly supporting the quality control work in drug research, development, and production processes.

  • Application Fields:

  • Quality Control: As an impurity reference standard, it is used to establish and validate the detection methods for impurities in Lapatinib bulk drugs and formulations, ensuring that the sensitivity and specificity of the detection methods meet strict pharmaceutical quality standards and guaranteeing drug quality and safety.

  • Process Optimization: During the production of Lapatinib, by monitoring the content of this impurity and analyzing the reaction steps and stages of its generation, it helps to optimize the synthesis process, reduce the amount of impurity generation, and improve product quality and production efficiency.

  • Stability Studies: In drug stability tests, it explores the change rules of this impurity under different storage conditions (such as temperature, humidity, light), providing key data support for determining the shelf life and suitable storage conditions of drugs.


  • Background Description: Lapatinib is a key targeted drug for the treatment of HER2-positive breast cancer. In its research, development, production, and quality control processes, impurity research is a core link to ensure drug safety and effectiveness. The presence of impurities may interfere with the normal mechanism of the drug and even cause potential adverse reactions. As a related impurity of Lapatinib, in-depth research on Lapatinib Impurity 12 helps to comprehensively and accurately evaluate the quality of Lapatinib drugs, improve the drug quality evaluation system, and ensure the safety and effectiveness of clinical medication.

  • Research Status: Currently, research on Lapatinib Impurity 12 is continuously deepening. In terms of detection technology, researchers are actively exploring advanced detection methods such as Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) and high-resolution mass spectrometry to achieve high-precision detection of trace impurities. In the study of impurity generation mechanisms, the formation causes and influencing factors are deeply analyzed by simulating drug synthesis reactions and storage environments, providing a theoretical basis for controlling impurities from the source. In addition, research on the impact of this impurity on the efficacy and safety of Lapatinib is also gradually being carried out, aiming to further clarify its role in drug quality evaluation and provide more comprehensive theoretical support for rational clinical medication

NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 




Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
VIP3Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2026-03-12
VIP3Y
SHANDONG BOYUAN PHARMACEUTICAL CO., LTD.
2026-05-21
VIP2Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2026-05-20
INQUIRY
西城区| 三门峡市| 内乡县| 高清| 鲁甸县| 金溪县| 乐亭县| 苏州市| 连山| 鄱阳县| 上杭县| 广昌县| 东兴市| 华宁县| 巴楚县| 鄯善县| 沙雅县| 中江县| 临湘市| 建德市| 林口县| 清徐县| 旬阳县| 宝兴县| 广宁县| 遂昌县| 历史| 宁陕县| 繁昌县| 托克逊县| 荔浦县| 平谷区| 安仁县| 库车县| 双峰县| 固安县| 河池市| 兰坪| 阜阳市| 马尔康县| 杨浦区|